| Pharmaceutical Information |
| Drug Name |
Zinc acetate |
| Drug ID |
BADD_D02386 |
| Description |
Not Available |
| Indications and Usage |
Zinc can be used for the treatment and prevention of zinc deficiency/its consequences, including stunted growth and acute diarrhea in children, and slowed wound healing. It is also utilized for boosting the immune system, treating the common cold and recurrent ear infections, as well as preventing lower respiratory tract infections [L2172].
|
| Marketing Status |
approved; investigational |
| ATC Code |
A16AX05 |
| DrugBank ID |
DB14487
|
| KEGG ID |
D06408
|
| MeSH ID |
D019345
|
| PubChem ID |
11192
|
| TTD Drug ID |
Not Available
|
| NDC Product Code |
64162-0219; 57844-208; 50017-028; 57844-215; 59555-200; 70334-155 |
| UNII |
FM5526K07A
|
| Synonyms |
Zinc Acetate | Galzin | Zinc Acetate Dihydrate | Anhydrous Zinc Acetate | Zinc Acetate, Anhydrous | Zinc Acetate Anhydrous |
|
| Chemical Information |
| Molecular Formula |
Zn(C2H3O2)2 |
| CAS Registry Number |
557-34-6; 5970-45-6 |
| SMILES |
CC(=O)[O-].CC(=O)[O-].[Zn+2] |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
|
|
|
